Celgene Corporation

NJ · United States · Reporting entity ID 100000000343

Total reported 2019–2025

$687.8M

#27 of 2,960 reporting companies — 0.8% of all reported industry payments

$81.2M in general payments across 383,886 records, plus $606.7M in research funding across 15,087 records.

How it breaks down

General payments $81,172,605

Research funding $606,650,713

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.